282 related articles for article (PubMed ID: 12494093)
21. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus.
Gleason CB; Stoddard MF; Wagner SG; Longaker RA; Pierangeli S; Harris EN
Am Heart J; 1993 Apr; 125(4):1123-9. PubMed ID: 8465738
[TBL] [Abstract][Full Text] [Related]
22. [A case report on mitral valve replacement associated with antiphospholipid syndrome in systemic lupus erythematosus].
Araki Y; Tajima K; Shimomura T; Abe T; Yoshikawa M; Io A; Tuzuki T; Suenaga Y
Kyobu Geka; 1997 Jun; 50(6):480-2. PubMed ID: 9185445
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus.
Ruiz D; Oates JC; Kamen DL
Am J Med Sci; 2018 Mar; 355(3):293-298. PubMed ID: 29549933
[TBL] [Abstract][Full Text] [Related]
24. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus.
Alarcón-Segovia D; Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J
Semin Arthritis Rheum; 1992 Apr; 21(5):275-86. PubMed ID: 1604324
[TBL] [Abstract][Full Text] [Related]
25. Overt congestive heart failure with mitral and aortic regurgitation due to antiphospholipid syndrome in a patient with systemic lupus erythematosus.
Morita H; Daido H; Suwa T; Mune T; Yoshino K; Isomura Y; Tanahashi T; Takeda N; Ishizuka T; Yasuda K
Intern Med; 2000 Jun; 39(6):506-11. PubMed ID: 10852175
[TBL] [Abstract][Full Text] [Related]
26. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome.
Pardos-Gea J; Cortés-Hernández J; Castro-Marrero J; Balada E; Ordi-Ros J
Clin Rheumatol; 2017 Jun; 36(6):1401-1406. PubMed ID: 28283766
[TBL] [Abstract][Full Text] [Related]
28. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment.
Nesher G; Ilany J; Rosenmann D; Abraham AS
Semin Arthritis Rheum; 1997 Aug; 27(1):27-35. PubMed ID: 9287387
[TBL] [Abstract][Full Text] [Related]
29. A Meta-analysis and Systematic Review of Valvular Heart Disease in Systemic Lupus Erythematosus and Its Association With Antiphospholipid Antibodies.
Hussain K; Gauto-Mariotti E; Cattoni HM; Arif AW; Richardson C; Manadan A; Yadav N
J Clin Rheumatol; 2021 Dec; 27(8):e525-e532. PubMed ID: 32558678
[TBL] [Abstract][Full Text] [Related]
30. [Heart valve involvement in systemic lupus erythematosus: an echocardiographic study].
Marcon C; Moro E; Sforza P; Piccoli G; Maresca MC; Adami A
G Ital Cardiol; 1992 Nov; 22(11):1301-8. PubMed ID: 1297616
[TBL] [Abstract][Full Text] [Related]
31. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus.
Roldan CA; Shively BK; Crawford MH
N Engl J Med; 1996 Nov; 335(19):1424-30. PubMed ID: 8875919
[TBL] [Abstract][Full Text] [Related]
32. Isolated Tricuspid Valve Libman-Sacks Endocarditis in Systemic Lupus Erythematosus with Secondary Antiphospholipid Syndrome.
Unic D; Planinc M; Baric D; Rudez I; Blazekovic R; Senjug P; Sutlic Z
Tex Heart Inst J; 2017 Apr; 44(2):147-149. PubMed ID: 28461804
[TBL] [Abstract][Full Text] [Related]
33. [Ocular manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome].
Ostanek L; Modrzejewska M; Bobrowska-Snarska D; Brzosko M
Pol Arch Med Wewn; 2007; 117 Suppl():18-23. PubMed ID: 18778014
[TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
35. [Arterial hypertension and the antiphospholipid syndrome].
Nasonov EL; Karpov IuA; Alekberova ZS; Vil'chinskaia MIu; Fomicheva OA; Aleksandrova EN; Reshetniak TM; Kliukvina NG; Andreev AIa
Ter Arkh; 1996; 68(2):37-40. PubMed ID: 8771655
[TBL] [Abstract][Full Text] [Related]
36. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Chartash EK; Lans DM; Paget SA; Qamar T; Lockshin MD
Am J Med; 1989 Apr; 86(4):407-12. PubMed ID: 2929627
[TBL] [Abstract][Full Text] [Related]
37. Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies.
Leszczyński P; Straburzyńska-Migaj E; Korczowska I; Łacki JK; Mackiewicz S
Clin Rheumatol; 2003 Dec; 22(6):405-8. PubMed ID: 14677016
[TBL] [Abstract][Full Text] [Related]
38. Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus.
Martin-Rodriguez S; Reverter JC; Tàssies D; Espinosa G; Heras M; Pino M; Escolar G; Diaz-Ricart M
Lupus; 2015 Oct; 24(11):1143-9. PubMed ID: 25824235
[TBL] [Abstract][Full Text] [Related]
39. Transcatheter aortic valve replacement for advanced valvular disease in active SLE and APS.
Bert JS; Abdullah M; Dahle TG; Gertner E
Lupus; 2013 Sep; 22(10):1046-9. PubMed ID: 23884983
[TBL] [Abstract][Full Text] [Related]
40. [Cardiovascular abnormalities in systemic lupus erythematosus patients in echocardiographic assessment].
Ostanek L; Płońska E; Peregud-Pogorzelska M; Mokrzycki K; Brzosko M; Fischer K; Fliciński J
Pol Merkur Lekarski; 2006 Mar; 20(117):305-8. PubMed ID: 16780262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
